Skip to content
EMA logo

The European Medicines Agency is evaluating clinical trial design in PSC.

PSC Support open consultation response to the The European Medicines Agency 'Concept paper on the need for the development of a reflection paper on regulatory requirements for the development of medicinal products for chronic non-infectious liver diseases (PBC, PSC, NASH)’ (EMA/CHMP/197320/2017). Submitted as a Word document August 2017.

PSC Support was also invited to represent PSC patients at the EMA stakeholder interaction meeting  in December 2018 and Martine Walmsley, Chair of Trustees of PSC Support presented the patient perspective in PSC medicine development.

Get involved

Help us work towards a cure for PSC. #LetsBeatPSC